Cargando…
Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer: Physician's Choices
The choice of adjuvant hormonal therapy in postmenopausal women with hormone receptor positive breast cancer has remained a matter of controversy and debate. The variety of agents is available, with each claiming to be superior. This clinical survey was undertaken to get an impression of the physici...
Autores principales: | Shaikh, Asim Jamal, Kumar, Shiyam, Raza, Sajjad, Mehboob, Maria, Ishtiaq, Osama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523410/ https://www.ncbi.nlm.nih.gov/pubmed/23304528 http://dx.doi.org/10.1155/2012/849592 |
Ejemplares similares
-
Controversies in the hormonal adjuvant therapy of postmenopausal patients
por: Dowsett, M
Publicado: (2009) -
Does HER2/neu overexpression in breast cancer influence adjuvant chemotherapy and hormonal therapy choices by Ontario physicians? A physician survey
por: Myers, J.A., et al.
Publicado: (2006) -
Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids
por: Francini, G, et al.
Publicado: (2006) -
Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women
por: Kittaneh, Muaiad, et al.
Publicado: (2011) -
Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)